Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
105.95
USD
1.32%
Market Closed
Market Cap:
$183.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abbott Laboratories
NYSE:ABT
|
US |
|
VAT Group AG
SIX:VACN
|
CH |
|
W
|
WPP PLC
XMUN:0WPA
|
UK |
|
Sagimet Biosciences Inc
NASDAQ:SGMT
|
US |
|
JGC Holdings Corp
OTC:JGCCF
|
JP |
|
R
|
Ryerson Holding Corp
F:7RY
|
US |
|
T
|
Thai Oil PCL
SET:TOP
|
TH |
|
Q
|
Quanta Services Inc
F:QAA
|
US |
|
Global Compliance Applications Corp
OTC:FUAPF
|
CA |
|
Altisource Portfolio Solutions SA
NASDAQ:ASPS
|
LU |
|
Fairchem Organics Ltd
BSE:543252
|
IN |
|
Assembly Biosciences Inc
NASDAQ:ASMB
|
US |
|
F
|
Fairfax Financial Holdings Ltd
OTC:FRFHF
|
CA |
Wall St Price Targets
ABT Price Forecast
Based on 29 analysts
Based on 29 analysts
+16% Upside
from
$105.95
today
Abbott Laboratories (ABT)’s 12-month stock price forecast through October 2027 has a consensus target of $122.4, implying 16% upside. The forecast is based on price targets from 29 Wall Street analysts.
ABT Analyst Rating
Based on 28 analysts
Based on 28 analysts
Analysts rate ABT Buy, with 23 of 28 recommending Buy or Strong buy.
Abbott Laboratories Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
122.4
USD
122.4
USD
According to Wall Street analysts, the average 1-year price target for ABT is 122.4 USD with a low forecast of 104.03 USD and a high forecast of 142.8 USD.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
17%
17%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 17%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.